Health literacy intervention on type 2 diabetes in China
| ISRCTN | ISRCTN76130594 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN76130594 |
| Secondary identifying numbers | Grant 13-159 |
- Submission date
- 27/08/2014
- Registration date
- 22/09/2014
- Last edited
- 02/01/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English Summary
Background and study aims
Type 2 diabetes is a chronic condition that causes the amount of sugar in a persons blood to be too high. It happens when the body doesnt produce enough insulin or doesnt respond to insulin very well (insulin resistance). It can cause a number of long-term health problems such as kidney failure and limb amputation, and can lead to partial or complete blindness. It is therefore very important for patients to make changes to their lifestyle and learn how to manage their diabetes. In this study, we are looking at how a modified Chinese version of a set of materials developed to help patients understand and self-manage their condition (Diabetes Education Toolkit) can help them to keep the glucose in the blood at a healthy level (glycemic control). The studys findings should help to show the importance of people understanding their condition in terms of them better being able to manage their disease and improve their health.
Who can participate?
Adults aged at least 18 with type 2 diabetes, hemoglobin A1c ≥ 7.5%, from eight communities of Shanghai, China.
What does the study involve?
The participants are randomly allocated into one of two groups (an intervention and a control group). Their hemoglobin A1c levels are measured and they take part in a survey that assesses their health and diabetes literacy. The control group then are treated as usual and the intervention group tale part in a comprehensive health literacy course for 12 months. Follow up surveys and measurements are carried out for all patients at 3, 6, 12 and 24 months after the start of the study where we compare the HbA1c level between the two groups.
What are the possible benefits and risks of participating?
The participants in the intervention group will obtain additional education on diabetes self-management. There will be no immediate direct benefit for those in the control group. But there should be benefits to all diabetes patients in the future, particularly for those with low literacy levels, because the results of the study are likely to influence how the government provides healthcare services in the future. There are no risks to taking part.
Where is the study run from?
Fudan University in collaboration with Vanderbilt University and Shanghai CDC (China)
When is the study starting and how long is it expected to run for?
January 2015 to December 2016
Who is funding the study?
China Medical Board (CMB) (USA)
Who is the main contact?
Professor Wanghong Xu
wanghong.xu@fudan.edu.cn
Contact information
Scientific
138 Yi Xue Yuan Road
Shanghai
200032
China
Study information
| Study design | A cluster randomized controlled trial (RCT) |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Other |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | A randomized trial on using a comprehensive health literacy strategy to improve self-management skills and glycemic control in chinese patients with type 2 diabetes |
| Study hypothesis | Participants randomized to the intervention arm will have significant improvements in HbA1C, blood pressure, lipids, self-management behavior, self-efficacy, and other patient outcomes important to improving diabetes care when compared to the control group participants. |
| Ethics approval(s) | IRB of School of Public Health, Fudan University (IRB00002408 & FWA00002399), 28/06/2013, ref. IRB#2013-06-0451 |
| Condition | Type 2 diabetes |
| Intervention | The intervention will include two main components: 1. Modified Chinese version of Diabetes Education Toolkit, a set of plain-language tools to aid provider-patient communication about diabetes management 2. A modified Chinese version of Clear Health Communication Curriculum (CHCC), a structured training program for healthcare providers to improve diabetes-related counseling communication skills, with specific attention to issues of literacy and numeracy Control group: Will receive usual care which refers to education according to the Chinese Guideline for Diabetes Care and Education, which is widely used in China. |
| Intervention type | Other |
| Primary outcome measure | The primary outcome will be changes in HbA1c at baseline and at 3, 6, 12, and 24 months of intervention. HbA1c level will be measured by a blood test. |
| Secondary outcome measures | Other measures include self-care behaviors, blood pressure, cholesterol, and utilization of clinical services. Incremental costs per behavioral, biologic and QALY change will also be determined. This will be measured at baseline and at 3, 6, 12, and 24 months of intervention. |
| Overall study start date | 01/01/2015 |
| Overall study end date | 31/12/2016 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 85 Years |
| Sex | Both |
| Target number of participants | 800 |
| Total final enrolment | 799 |
| Participant inclusion criteria | 1. Patient has a clinical diagnosis of type 2 diabetes 2. Age 18-85 years 3. Most recent HbA1c >=7.5% 4. Patient agrees to participate in the study for the full two years duration |
| Participant exclusion criteria | 1. Poor visual acuity (vision worse than 20/50 using Rosenbaum Pocket Screener) 2. Significant dementia, or psychosis (by health provider report or chart review) 3. Terminal illness with anticipated life expectancy < 2 years |
| Recruitment start date | 01/01/2015 |
| Recruitment end date | 31/12/2016 |
Locations
Countries of recruitment
- China
Study participating centre
200032
China
Sponsor information
Government
2 Arrow Street
Cambriage
MA 02138
United States of America
| Website | http://www.chinamedicalboard.org |
|---|
Funders
Funder type
Government
Private sector organisation / Trusts, charities, foundations (both public and private)
- Alternative name(s)
- CMB
- Location
- United States of America
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 20/12/2014 | Yes | No | |
| Results article | results | 19/11/2019 | 02/01/2020 | Yes | No |
Editorial Notes
02/01/2020: The following changes have been made:
1. Publication reference added.
2. The total final enrolment number has been added from the reference.
